(Q44301237)

English

Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

platelet aggregation

1 reference

based on heuristic

inferred from title

author name string

David J Schneider

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Howard C Herrmann

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nasser Lakkis

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Frank Aguirre

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Man Wai Lo

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kuo Chang Yin

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Atul Aggarwal

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Samer S Kabbani

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Peter M DiBattiste

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

334-336

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Platelet inhibition with tirofiban early during percutaneous coronary intervention: dosing revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903163-6

7 January 2021

Identifiers

10.1016/S0002-9149(02)03163-6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44301237&oldid=2109287224"